BioSpace News Archive

Bio NC

Milestone Pharmaceuticals Announces $125 Million Strategic Financing with RTW Investments to Support the Advancement of Etripamil for PSVT

Milestone Pharmaceuticals Inc. announced that it has entered into a $125 million strategic funding agreement with existing shareholder, RTW Investments, LP and certain of its affiliates.

March 28, 2023
·
8 min read
Genetown

Theseus Pharmaceuticals to Participate in the Cantor Future of Oncology Virtual Symposium

Theseus Pharmaceuticals, Inc. today announced that the company will participate in the Cantor Future of Oncology Virtual Symposium, taking place April 3-5, 2023.

March 28, 2023
·
1 min read
Deals

TC BioPharm Announces Pricing of $5.5 Million Public Offering

TC BioPharm today announced the pricing of a public offering of 3,437,500 of its American Depositary Shares (the “ADSs”) (or pre-funded warrants in lieu thereof) and associated Series C Warrant.

March 28, 2023
·
4 min read
Biotech Beach

bioAffinity Technologies Announces Publication of Peer-Reviewed Paper on Proprietary Beads Used in CyPath® Lung for Noninvasive Detection of Early-Stage Lung Cancer

bioAffinity Technologies Announces Publication of Peer-Reviewed Paper on Proprietary Beads Used in CyPath ® Lung for Noninvasive Detection of Early-Stage Lung Cancer.

March 28, 2023
·
3 min read
Deals

SunMed to Acquire Respiratory and Anesthesia Consumables Business of Vyaire Medical

SunMed announced it has entered into a definitive agreement with Vyaire Medical, under which SunMed will acquire Vyaire’s business unit that manufactures and markets respiratory and anesthesia consumables focused on airway management and operative care.

March 28, 2023
·
6 min read
Business

Factorial Biotechnologies collaborates with Watchmaker Genomics to dramatically simplify single-cell sequencing

Factorial Biotechnologies has announced a collaboration with Watchmaker Genomics, a life sciences company that specializes in developing high-stringency applications for reading, writing, and editing of DNA and RNA.

March 28, 2023
·
3 min read
Business

Waters Corporation Appoints Richard Fearon to Board of Directors

Waters™ Corporation (NYSE:WAT) today announced the appointment of Richard Fearon to its Board of Directors, effective March 27, 2023.

March 28, 2023
·
3 min read
Drug Development

Direct Biologics Announces First Patient Dosed with ExoFlo™ in a Phase 1 Clinical Trial for Medically Refractory Ulcerative Colitis

Direct Biologics, LLC announces that the first patient has been dosed in its Phase 1 clinical trial evaluating ExoFlo™ for the treatment of patients with medically refractory ulcerative colitis (UC).

March 28, 2023
·
4 min read
Genetown

Mustang Bio to Participate in Cantor’s The Future of Oncology Virtual Symposium

Mustang Bio, Inc. today announced that Manuel Litchman, M.D., President and Chief Executive Officer, will participate in Cantor’s The Future of Oncology Virtual Symposium.

March 28, 2023
·
3 min read
Business

Simulations Plus Enters New Strategic Collaboration to Discover Anticancer Therapies Through Its AI-Driven Drug Design Technology

Simulations Plus, Inc. today announced that it established a strategic research collaboration with the Sino-American Cancer Foundation (SACF).

March 28, 2023
·
5 min read